Skip to content

Shop BLIS Probiotics >

  • Solutions

    Probiotic Portfolio

    BLIS K12™

    BLIS M18™

    BLIS Q24™

    Health Areas

    ENT Health

    Immune Health

    Dental Health

    Skin Health

    Finished Goods

    BLIS Q24™ Live Probiotic Serum

    BLIS K12™ Throat Health Lozenge

    BLIS K12™ Immunity Lozenge

    BLIS K12™ Immunity Kids Powder

    BLIS K12™ Fresh Breath Lozenge

    BLIS M18™ Teeth & Gums Lozenge

  • Work With Us

    Private Label

    Ingredients

    R&D and Formulations

  • Research

    Clinical Studies

    Scientific Collaboration

  • Investor Centre

    NZX Announcements

    Annual & Half Year Reports

    Corporate Governance

    Charters & Policies

    FAQs

    Key Dates

    Investor Enquiries

  • Company

    Our Mission

    Our Story

    Facilities

    Partners

  • Knowledge

    Press

    Awards

    White Papers

    Events

CONTACT US
CONTACT US

BLIS PROBIOTICS FEATURE ON BULLETPROOF RADIO WITH DAVE ASPREY

  • By BLIS
  • March 2021

Professor John Tagg recently spoke with Dave Asprey of Bulletproof Radio about his years of dedicated research and development of BLIS K12TM and BLIS M18TM that began at Otago University and then lead to the establishment of BLIS Technologies.
This insightful podcast talks about how it all began, with John suffering from Group A Strep throat infections as a child and his journey to finding a probiotic solution.

Listen here: 

SIMILAR ARTICLES FOR YOU

Probiotics for cold and flu

BLIS K12™ for Upper Respiratory Illnesses: Boosting Immune Health Naturally

26/06/2023

Upper respiratory illnesses, such as the common cold and flu, have a significant impact on our daily lives. To combat these upper respiratory illnesses naturally, a potential solution may be closer than you think: BLIS K12™. T

Read More

WHITEPAPER: STUDIES SHOW BLIS M18™ ENHANCES DENTAL AND GINGIVAL HEALTH

27/11/2023

In our latest whitepaper, shows BLIS M18™ significantly reduces gingivitis in young adults and improved dental health in pre-schoolers that had dental caries, reducing them by 81%.

Read More

Breaking the Halitosis Cycle: BLIS K12™ Oral Probiotics to the Rescue

11/09/2023

Halitosis, commonly known as bad breath, can be a persistent and embarrassing problem affecting millions worldwide, with the halitosis treatment market size valued at USD 10.93 billion in 2021…

Read More
Probiotic treatment for bad breath / halitosis

WHITEPAPER: TARGETING THE SOURCE OF HALITOSIS WITH BLIS K12™

29/08/2023

Halitosis (bad breath) can be a major source of embarrassment and social anxiety for some people. Bad breath is estimated to affect half the adult population at some time, to some extent. BLIS K12™ has been scientifically proven to inhibit bacteria that cause halitosis…

Read More

STUDIES SHOW BLIS M18™ ENHANCES DENTAL AND GINGIVAL HEALTH

Download the white paper

Solutions

  • Probiotic Portfolio
  • Health Areas
  • Finished Goods

WORK WITH US

  • Ingredients
  • Private Label
  • R&D and Formulations

Other Links

  • Investor Centre
  • Privacy Policy
  • Terms & Conditions
  • Terms of Trade

Connect With Us

  • @blis-technologies-limited
    @blis-technologies-limited
  • Info@blis.co.nz
    Info@blis.co.nz
  • Buy BLIS Probiotics Online:
BlisProbiotics.co.NZ

© 2023 Blis Technologies ·
Website crafted by Drive Digital

Blis Probiotics Retail

Are you wanting to
purchase BLIS Probiotics?

Visit our retail website